Ignite Creation Date:
2024-05-06 @ 4:42 PM
Last Modification Date:
2024-10-26 @ 2:14 PM
Study NCT ID:
NCT05062980
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-26
First Post:
2021-09-20
Brief Title:
Quaratusugene Ozeplasmid Reqorsa in Combination with Pembrolizumab in Previously Treated Non-Small Lung Cancer
Sponsor:
Genprex Inc
Organization:
Genprex Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-30
Start Date Type:
ACTUAL
Primary Completion Date:
2027-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-11
Completion Date Type:
ESTIMATED
First Submit Date:
2021-09-20
First Submit QC Date:
September 29 2021
Study First Post Date:
2021-09-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-30
Last Update Post Date:
2024-06-26
Last Update Post Date Type:
ACTUAL